| scholarly article | Q13442814 |
| P2093 | author name string | David M Mosser | |
| Matthias Mack | |||
| Dalit Strauss-Ayali | |||
| Ann E Field | |||
| Sean M Conrad | |||
| P2860 | cites work | Chemokine receptors and their role in inflammation and infectious diseases | Q28144282 |
| International union of pharmacology. XXII. Nomenclature for chemokine receptors | Q28145705 | ||
| CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 c | Q28588634 | ||
| Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension | Q29547330 | ||
| Monocyte and macrophage heterogeneity | Q29547438 | ||
| Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 | ||
| Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. | Q33540290 | ||
| Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. | Q33602903 | ||
| Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection | Q33946585 | ||
| Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major | Q34001286 | ||
| Interleukin-12 regulates chemokine gene expression during the early immune response to Leishmania major | Q34714626 | ||
| Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis | Q34725975 | ||
| Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis | Q35165095 | ||
| Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies | Q35173613 | ||
| Current treatment approaches to leishmaniasis | Q35539735 | ||
| Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells | Q35698582 | ||
| The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. | Q36370082 | ||
| Selective suppression of interleukin-12 induction after macrophage receptor ligation | Q36377302 | ||
| Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor | Q36380911 | ||
| Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice | Q36400287 | ||
| Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis | Q36403789 | ||
| A new view on cutaneous dendritic cell subsets in experimental leishmaniasis | Q36512270 | ||
| Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. | Q36532495 | ||
| Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression | Q36721065 | ||
| Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1. | Q40765518 | ||
| The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis. | Q41597341 | ||
| Monocyte chemotactic protein-1 stimulates the killing of leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4. | Q43511349 | ||
| Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide | Q44000011 | ||
| TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection | Q44308127 | ||
| Chemokine CC receptor 2 is important for acute control of cardiac parasitism but does not contribute to cardiac inflammation after infection with Trypanosoma cruzi | Q46227691 | ||
| Monocyte heterogeneity and innate immunity. | Q53653050 | ||
| Early parasite containment is decisive for resistance to Leishmania major infection. | Q54166265 | ||
| IFN-gamma produced in vivo during the first two days is critical for resolution of murine Leishmania major infections. | Q54238497 | ||
| Leishmania major:Infection of Human Monocytes Induces Expression of IL-8 and MCAF | Q58800506 | ||
| The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes | Q67918535 | ||
| Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes | Q68821142 | ||
| Gene splicing by overlap extension | Q70662421 | ||
| Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis | Q71071269 | ||
| Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor | Q71526283 | ||
| Interaction between the innate and the acquired immune system following infection of different mouse strains with Leishmania major | Q72173620 | ||
| Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages | Q73188252 | ||
| A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis | Q73938142 | ||
| Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators | Q77691387 | ||
| A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species | Q78359499 | ||
| Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages | Q78560006 | ||
| Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection | Q79361616 | ||
| Differential roles of CCL2 and CCR2 in host defense to coronavirus infection | Q80942488 | ||
| Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice | Q95721029 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 653-665 | |
| P577 | publication date | 2006-11-06 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages | |
| P478 | volume | 75 |
| Q36346773 | CCR-2 neutralization augments murine fresh BMC activation by Staphylococcus aureus via two distinct mechanisms: at the level of ROS production and cytokine response |
| Q36855774 | CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system |
| Q46878999 | Caffeic acid combined with autoclaved Leishmania major boosted the protection of infected BALB/c mice by enhancing IgG2 production, IFN-γ/TGF-β and iNO synthase/arginase1 ratios, and the death of infected phagocytes |
| Q55072911 | Immunology and Genetic of Leishmania infantum: The Role of Endonuclease G in the Apoptosis. |
| Q35102707 | Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections |
| Q36971309 | Invasion and intracellular survival by protozoan parasites |
| Q92767806 | Investigating immune responses to parasites using transgenesis |
| Q36133707 | Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion. |
| Q91771590 | Monocyte subpopulations as important biomarkers of resistence and susceptibility during experimental infection with Leishmania (Leishmania) major |
| Q34065898 | Monocyte-mediated defense against microbial pathogens. |
| Q42008585 | Murine immune response induced by Leishmania major during the implantation of paraffin tablets |
| Q35213593 | Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection |
| Q27005837 | Protection and pathology during parasite infection: IL-10 strikes the balance |
| Q35913436 | Reduced pathology following infection with transgenic Leishmania major expressing murine CD40 ligand |
| Q35036907 | The absence of CCR7 results in dysregulated monocyte migration and immunosuppression facilitating chronic cutaneous leishmaniasis |
| Q34445135 | Therapeutic antibodies directed at G protein-coupled receptors |
| Q37081691 | Transgenic Leishmania and the immune response to infection |
Search more.